Nicastrin Antibody [D2C5] | Primary Antibodies

Application: Reactivity: Human, Mouse, Rat, Hamster, Monkey

Usage Information

Dilution
WB1:1000

Application
WB

Reactivity
Human, Mouse, Rat, Hamster, Monkey

Source
Rabbit Monoclonal Antibody

Storage Buffer
PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3

Storage (from the date of receipt)
-20°C (avoid freeze-thaw cycles), 2 years

Predicted MW
110 kDa, 120 kDa

Datasheet & SDS

Biological Description

Specificity
Nicastrin Antibody [D2C5] detects endogenous levels of total Nicastrin protein.

Clone
D2C5

Synonym(s)
Nicastrin; NCSTN

Background
Nicastrin functions as the essential glycoprotein subunit of the γ-secretase protease complex alongside presenilin, APH-1, and PEN-2, enabling intramembrane proteolysis of type I transmembrane substrates following ectodomain shedding. Nicastrin organizes a large, heavily glycosylated extracellular domain with a substrate-binding pocket flanked by a single C-terminal transmembrane helix that anchors the complex within lipid rafts, while conserved glutamate and tyrosine residues in the DYIGS motif line a hydrophilic cleft recognizing free N-termini of cleaved substrates. The Nicastrin ectodomain directly captures the nascent amino terminus generated by α- or β-secretase cleavage of APP and Notch, recruiting these substrates into the active site through conformational stabilization that positions membrane stubs for presenilin-mediated endoproteolysis via two juxtaposed transmembrane aspartates. This docking mechanism exhibits substrate selectivity where mutations disrupting the binding pocket differentially impair Aβ40 versus Aβ42 production or Notch intracellular domain release, with Nicastrin stabilization preventing APH-1 and full-length presenilin degradation through subcomplex formation essential for Golgi-to-plasma membrane trafficking. Complex maturation requires sequential glycosylation of Nicastrin asparagines that shield hydrophobic surfaces during assembly, culminating in PEN-2-induced presenilin endoproteolysis that activates the catalytic core. Nicastrin coordinates neuronal differentiation through Notch signaling and synaptic plasticity via regulated intramembrane proteolysis of ErbB4 and cadherins, with ubiquitous expression ensuring a broad substrate repertoire across tissues. Dysregulation through familial mutations elevates Aβ42/40 ratios in Alzheimer's disease while disrupting developmental Notch patterning.

Background

Nicastrin functions as the essential glycoprotein subunit of the γ-secretase protease complex alongside presenilin, APH-1, and PEN-2, enabling intramembrane proteolysis of type I transmembrane substrates following ectodomain shedding. Nicastrin organizes a large, heavily glycosylated extracellular domain with a substrate-binding pocket flanked by a single C-terminal transmembrane helix that anchors the complex within lipid rafts, while conserved glutamate and tyrosine residues in the DYIGS motif line a hydrophilic cleft recognizing free N-termini of cleaved substrates. The Nicastrin ectodomain directly captures the nascent amino terminus generated by α- or β-secretase cleavage of APP and Notch, recruiting these substrates into the active site through conformational stabilization that positions membrane stubs for presenilin-mediated endoproteolysis via two juxtaposed transmembrane aspartates. This docking mechanism exhibits substrate selectivity where mutations disrupting the binding pocket differentially impair Aβ40 versus Aβ42 production or Notch intracellular domain release, with Nicastrin stabilization preventing APH-1 and full-length presenilin degradation through subcomplex formation essential for Golgi-to-plasma membrane trafficking. Complex maturation requires sequential glycosylation of Nicastrin asparagines that shield hydrophobic surfaces during assembly, culminating in PEN-2-induced presenilin endoproteolysis that activates the catalytic core. Nicastrin coordinates neuronal differentiation through Notch signaling and synaptic plasticity via regulated intramembrane proteolysis of ErbB4 and cadherins, with ubiquitous expression ensuring a broad substrate repertoire across tissues. Dysregulation through familial mutations elevates Aβ42/40 ratios in Alzheimer's disease while disrupting developmental Notch patterning.

References
https://pubmed.ncbi.nlm.nih.gov/16096062/ https://pubmed.ncbi.nlm.nih.gov/15711015/

Reference Table for Selecting PVDF Membrane Pore Size Specifications

Protein Size (kDa)	PVDF Transfer Membrane Pore Size (μm)
< 10	0.22
10-20	0.22
20-30	0.45
30-45	0.45
45-70	0.45
80-100	0.45
100-140	0.45
> 140	0.45

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Protein Size (kDa)	Separating Gel Percentage
4-40	20%
12-45	15%
10-70	12.5%
15-100	10%
25-100	8%
60-210	5%